Nucleic acid-based therapy for coronavirus disease 2019

The coronavirus disease 2019 (COVID-19), the pandemic that originated in China has already spread into more than 190 countries, resulting in huge loss of human life and many more are at the stake of losing it; if not intervened with the best therapeutics to contain the disease. For that aspect, vari...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13811

Acceso en línea:

https://doi.org/10.1016/j.heliyon.2020.e05007
http://hdl.handle.net/20.500.12010/13811

Palabra clave:

Microbiology
Biotechnology
Molecular biology
Epidemiology
Virology
Regenerative medicine
Covid-19
SARS-CoV-2
Nucleic acid based therapy
siRNA
Ribozymes
DNAzymes
Aptamers
Antisense
Oligonucleotide
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)